Industries > Pharma > Global Biosimilars and Follow-On Biologics Market 2020-2030

Global Biosimilars and Follow-On Biologics Market 2020-2030

Monoclonal Antibodies (mAbs), Fusion Proteins, Insulin, Erythropoietin’s, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Growth Hormones, Fertility Hormones, Blood Disorders, Growth Hormone Deficiency, Autoimmune Diseases, Cancer, Diabetes, Infectious Diseases PLUS leading Biosimilars and Follow-On Biologics companies analysis

PUBLISHED: 30 April 2020
PAGES: 420
PRODUCT CODE: PHA0738

Clear
WOOCS 2.2.1

The global biosimilars and follow-on biologics market is estimated to have reached $19.87bn in 2019 and expected to grow at a CAGR of 7.1% in the first half of the forecast period. The market is dominated by Biosimilar Monoclonal Antibodies, this submarket is estimated to hold 36.5% share of this market in 2020.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 420-page report you will receive 131 tables and 90 figures– all unavailable elsewhere.

The 420-page report provides clear detailed insight into the global biosimilars and follow-on biologics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Biosimilars and Follow-on Biologics Market forecasts from 2020-2030

• Along with revenue prediction for the overall world market for biosimilars, our investigation shows forecasts to 2029 for 8 individual therapeutic submarkets:
• Monoclonal antibodies (mAbs)
• Fusion proteins
• Insulin
• Erythropoietin (EPO)
• Granulocyte colony-stimulating factor (G-CSF)
• Interferons
• Growth hormones
• Fertility hormones

• This report also shows revenue to 2030 for 11 individual submarkets within the above segments:
• Rituximab, infliximab, trastuzumab, adalimumab and bevacizumab
• Human insulin, insulin analogues, insulin glargine and insulin lispro
• Interferon alfa and interferon beta

Drugs Banner

• Our analyses show individual revenue forecasts to 2030 for 17 national markets:
• US
• Canada
• Japan
• Germany
• France
• UK
• Italy
• Spain
• Sweden
• Norway
• China
• India
• South Korea
• Russia
• Brazil
• South Africa
• Australia

Global Biosimilars and Follow-On Biologics Market 2020-2030

• Our study discusses the leading companies that are involved in the biosimilars and follow-on biologics industry:
• Amgen Inc
• Biocon Limited
• Celltrion Healthcare Co. Ltd
• Dong-A Socio Holdings Co. Ltd
• Dr.Reddy’s Labs (DRL)
• & Other Companies

• Our study provides a SWOT analysis of the biosimilars and follow-on biologics market.

• Our study discusses pressures, opportunities and other events affecting the biosimilars industry and market, including these influences:
Strategies for developing biosimilars – needs, demand, challenges and opportunities
Guidelines from regulators (FDA, EMA and others)
Patent challenges and data exclusivity for biopharmaceuticals
• Needs and opportunities in developing biosimilar mAbs, including rising incidence of cancers and increasing demand for lower-cost biologicals
• Developments in technology and operations for biosimilar drug production.

Visiongain’s study is intended for anyone requiring commercial analyses for the biosimilars and follow-on biologics market. You find data, trends and predictions.

Buy our report today Global Biosimilars and Follow-On Biologics Market: Monoclonal Antibodies (mAbs), Fusion Proteins, Insulin, Erythropoietin’s, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Growth Hormones, Fertility Hormones, Blood Disorders, Growth Hormone Deficiency, Autoimmune Diseases, Cancer, Diabetes, Infectious Diseases.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Biosimilars and Follow-On Biologics Market 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Global Biosimilars and Follow-On Biologics Market 2020-2030


Latest Pharma news

Visiongain Publishes Single-Cell Analysis Market Report 2022-2032

The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

26 May 2022

READ

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

READ

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

READ

Categories